ALL‐derived CAR T cells showed a marked post‐transductional increase in CD8+ T cells and reduced PD‐1 expression, aligning with their known proliferative advantage and superior clinical persistence.34, 35. The gene discussed is CD8A; the disease is acute lymphoblastic leukemia.